
Ovarian Cancer Drug Trial Began in Philadelphia
The Phase 2a study is now testing a new monotherapy for patients with platinum-resistant ovarian cancer.

The Phase 2a study is now testing a new monotherapy for patients with platinum-resistant ovarian cancer.